Article Information
History
- July 30, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Kenji Maeda1,*,
- Masayuki Amano2,
- Yukari Uemura3,
- Kiyoto Tsuchiya4,
- Tomoko Matsushima5,
- Kenta Noda5,
- Yosuke Shimizu3,
- Asuka Fujiwara1,
- Yuki Takamatsu1,
- Yasuko Ichikawa6,
- Hidehiro Nishimura6,
- Mari Kinoshita6,
- Shota Matsumoto6,
- Hiroyuki Gatanaga4,
- Kazuhisa Yoshimura7,
- Shin-ichi Oka4,
- Ayako Mikami3,
- Wataru Sugiura3,
- Toshiyuki Sato5,
- Tomokazu Yoshida5,
- Shinya Shimada6 and
- Hiroaki Mitsuya1,2,8,*
- 1Department of Refractory Viral Infections, National Center for Global Health and Medicine (NCGM) Research Institute, Tokyo, Japan
- 2Department of Clinical Sciences, Kumamoto University Hospital, Kumamoto, Japan
- 3Department of Clinical Sciences, NCGM, Tokyo, Japan
- 4AIDS Clinical Center, NCGM, Tokyo, Japan
- 5Sysmex Corporation, Hyogo, Japan
- 6JCHO Kumamoto General Hospital, Kumamoto, Japan
- 7Tokyo Metropolitan Institute for Public Health, Tokyo, Japan
- 8Experimental Retrovirology Section, HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
- ↵*Address correspondence to: Hiroaki Mitsuya (hmitsuya{at}hosp.ncgm.go.jp) or Kenji Maeda (kmaeda{at}ri.ncgm.go.jp), Hiroaki Mitsuya, MD, PhD., National Center for Global Health and Medicine (NCGM) Research Institute, 1-21-1 Toyama, Shijuku, Tokyo 162-8655, JAPAN, Tel: +81-3-3202-7181